Ownership history in ROYCE & ASSOCIATES LP · 12 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in APOLLO MEDICAL HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 348,331 | +88,978 | +34.3% | 0.09% | $8.6M | $24.81 |
| 2025 Q3 | REDUCED | 259,353 | -48,135 | -15.7% | 0.07% | $7.4M | $28.35 |
| 2025 Q2 | ADDED | 307,488 | +16,781 | +5.8% | 0.08% | $7.7M | $24.88 |
| 2025 Q1 | ADDED | 290,707 | +35,155 | +13.8% | 0.10% | $9.0M | $31.01 |
| 2024 Q4 | ADDED | 255,552 | +140,584 | +122.3% | 0.07% | $8.1M | $31.53 |
| 2024 Q3 | ADDED | 114,968 | +100,000 | +668.1% | 0.06% | $6.7M | $57.94 |
| 2024 Q2 | UNCHANGED | 14,968 | — | 0% | 0.01% | $607K | $40.56 |
| 2024 Q1 | REDUCED | 14,968 | -7,891 | -34.5% | 0.01% | $629K | $41.99 |
| 2019 Q1 | REDUCED | 22,859 | -42,125 | -64.8% | 0.00% | $419K | $18.32 |
| 2018 Q4 | REDUCED | 64,984 | -21,000 | -24.4% | 0.01% | $1.3M | $19.85 |
As of 2025 Q4 — sorted by position size